Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4249349 | Revista Española de Medicina Nuclear | 2006 | 4 Pages |
Abstract
Our results led us to the following: In patients having IDC of the breast, preoperative serum CA15.3 levels are associated with greater tumor size and distant metastasis, while pre-treatment CEA serum levels are associated moreover with axillary involvement; we have not observed any correlation between serum levels of both antigens and the hormonal status of the tumor; these results had physiopathological interest but reduced clinical value in pretreatment breast carcinomas due to their low sensitivity of both markers. However, they are useful in the follow-up of the patients when assesing serum concentrations of both markers, since they contribute to knowing the patients'clinical satus better.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
A. Ruibal, M. Garrido Pumar, J.I. Arias,